相关实验视频
Updated: Jul 15, 2026

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.7K
CDKN1A作为心力衰竭中衰老的目标:来自多组学研究的见解
Rutao Bian1,2, Li Zhang1,2, Dongyu Li1,2
1Department of Cardiology, Zhengzhou Hospital of Traditional Chinese Medicine, Zhengzhou, Henan, China.
Frontiers in pharmacology
|November 8, 2024
概括
这项研究表明,CDKN1A通过促进心肌细胞衰老与心力衰竭 (HF) 有因果关系. 结果确定CDKN1A是开发新型HF药物的治疗标.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 心肌细胞衰老是心力衰竭 (HF) 发病的一个关键因素.
- 对于HF发育和进展的确切触发因素和原因尚不清楚.
研究的目的:
- 为了研究心肌细胞衰老和HF之间的遗传联系.
- 使用多omics数据识别与HF相关的细胞衰老相关基因 (SRGs).
主要方法:
- 利用CellAge,SenMayo和scRNA-seq数据识别SRG并分析心脏细胞表达.
- 采用孟德尔随机化 (MR),包括两样 MR (TSMR) 和基于总结数据的 MR (SMR),以探索与高频的因果关系.
- 使用贝叶斯协同定位,cis-eQTL,cis-mQTL,cis-pQTL分析的验证结果,以及评估治疗点的药物可用性.
主要成果:
- 在心肌细胞中确定了39个SRG,CDKN1A在发现和验证组中显示与HF的因果关系.
- 通过SMR确认CDKN1A是HF的致病基因,将其甲基化与HF风险位置联系起来.
- 贝叶斯定位和遗传变异分析支持了这些结果;确定了两种潜在的治疗药物.
结论:
- 多omics数据揭示了CDKN1A在调节心肌细胞衰老中的作用.
- 确定CDKN1A作为HF药物开发的潜在治疗标.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

